BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16241945)

  • 1. Old and new risk factors for upper extremity deep venous thrombosis.
    Blom JW; Doggen CJ; Osanto S; Rosendaal FR
    J Thromb Haemost; 2005 Nov; 3(11):2471-8. PubMed ID: 16241945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
    Blom JW; Doggen CJ; Osanto S; Rosendaal FR
    JAMA; 2005 Feb; 293(6):715-22. PubMed ID: 15701913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
    Van Rooden CJ; Rosendaal FR; Meinders AE; Van Oostayen JA; Van Der Meer FJ; Huisman MV
    Haematologica; 2004 Feb; 89(2):201-6. PubMed ID: 15003896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    Vayá A; Todolí J; Ricart J; Estellés T; Mira Y; Villa P; Calabuig JR; Aznar J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):72-4. PubMed ID: 11190909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk factors for venous thrombosis in the elderly in a case-control study.
    Karasu A; Engbers MJ; Cushman M; Rosendaal FR; van Hylckama Vlieg A
    J Thromb Haemost; 2016 Sep; 14(9):1759-64. PubMed ID: 27377285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk.
    Vayá A; Mira Y; Mateo J; Falco C; Villa P; Estelles A; Corella D; Fontcuberta J; Aznar J
    Thromb Haemost; 2003 Mar; 89(3):452-7. PubMed ID: 12624627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
    Kreidy R; Irani-Hakime N
    Vasc Health Risk Manag; 2009; 5():627-33. PubMed ID: 19688103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis.
    Dentali F; Gianni M; Agnelli G; Ageno W
    J Thromb Haemost; 2008 Jan; 6(1):70-5. PubMed ID: 17988232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case-control study.
    van Adrichem RA; Debeij J; Nelissen RG; Schipper IB; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2014 Sep; 12(9):1461-9. PubMed ID: 25040873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.
    Mandalà M; Curigliano G; Bucciarelli P; Ferretti G; Mannucci PM; Colleoni M; Ventura A; Peruzzotti G; Severi G; Pelicci PG; Biffi R; Orsi F; Cinieri S; Goldhirsch A
    Ann Oncol; 2004 Apr; 15(4):590-3. PubMed ID: 15033664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.
    Rosendaal FR; Vessey M; Rumley A; Daly E; Woodward M; Helmerhorst FM; Lowe GD
    Br J Haematol; 2002 Mar; 116(4):851-4. PubMed ID: 11886391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
    Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
    Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.
    Kennedy M; Andreescu AC; Greenblatt MS; Jiang H; Thomas CA; Chassereau L; Wong C; Durda P; Cushman M
    Br J Haematol; 2005 Feb; 128(3):386-8. PubMed ID: 15667542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.